Recent Patents on Anti-Cancer Drug Discovery
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 4
Author(s): Frank Entschladen
Affiliation:
Export Options
About this article
Cite this article as:
Entschladen Frank , Meet Our Editorial Board Member, Recent Patents on Anti-Cancer Drug Discovery 2019; 14 (4) . https://dx.doi.org/10.2174/157489281404191220160818
DOI https://dx.doi.org/10.2174/157489281404191220160818 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
Call for Papers in Thematic Issues
Novel anti-cancer drugs in photoimmunotherapy management: from bench to translational research
In recent years, traditional cancer treatments, such as surgery, chemotherapy, and radiation treatment, etc., may damage the pathological tissue and normal cells. The ideal tumor treatment should be noninvasive, eliminating the primary tumor, making the body produce systemic tumor-specific immunity, eliminating metastases, and having less /no side effects. Recent Patents ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multidisciplinary Approach to Patient with Malignant Melanoma
Anti-Cancer Agents in Medicinal Chemistry PPAR-Gamma in Ulcerative Colitis: A Novel Target for Intervention
Current Drug Targets PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders
Current Drug Delivery Nanocosmetics: Past, Present and Future Trends
Recent Patents on Nanomedicine Strategies for Biology- and Molecular-Based Treatment of Myelodysplastic Syndromes
Current Drug Targets New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry HIV Infection Induces Morphometrical Changes on the Oral (Buccal Mucosa and Tongue) Epithelial Cells
Current HIV Research Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II)
Medicinal Chemistry Latest Results for Anti-Angiogenic Drugs in Cancer Treatment
Current Pharmaceutical Design ZIP4 is a Novel Diagnostic and Prognostic Marker in Human Pancreatic Cancer: A Systemic Comparison Between EUS-FNA and Surgical Specimens
Current Molecular Medicine Toxicity of Magnetic Resonance Imaging Agents: Small Molecule and Nanoparticle
Current Topics in Medicinal Chemistry Chemical Biology of mGlu4 Receptor Activation: Dogmas, Challenges, Strategies and Opportunities
Current Topics in Medicinal Chemistry Metallocarboxypeptidases: Emerging Drug Targets in Biomedicine
Current Pharmaceutical Design Editorial: Biodegradable Drug Delivery Systems for Cancer Therapy
Current Drug Delivery Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents
Current Medicinal Chemistry Editorial
Drug Delivery Letters Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Synthesis, Cytotoxic Evaluation, and Molecular Docking Studies of N-(7- hydroxy-4-methyl-2-oxoquinolin-1(2H)-yl)acetamide/benzamide Analogues
Letters in Drug Design & Discovery Novel Mediators of Vitamin D Signaling in Cancer and Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Personalized Peptide Vaccine for Treatment of Advanced Cancer
Current Medicinal Chemistry